Michael Hudson, CEO Mawson Resources (TSX:MAW) tells Proactiveinvestors at VRIC 2013 that at 3% gold averaging 100gms per ton gold the company is well blessed and places Mawson uniquely as an investment prospect. The drilling of the asset at Rompas is expected to start delivering results from February this year.
BioAlliance Pharma SA develops and manufactures drugs for the treatment of cancer and its associated pathologies. Its product offerings comprise...
Mawson Resources Ltd.
1090 West Georgia Street Suite 1305
Vancouver , BC V6E 3V7
SIC Code: 1094